108 related articles for article (PubMed ID: 38823030)
1. Clinical validation of the Ion Torrent Oncomine Myeloid Assay GX v2 on the Genexus Integrated Sequencer as a stand-alone assay for single-nucleotide variants, insertions/deletions, and fusion genes: Challenges, performance, and perspectives.
Krishnamurthy K; Chai J; Liu X; Wang Y; Naeem R; Goldstein DY
Am J Clin Pathol; 2024 Jun; ():. PubMed ID: 38823030
[TBL] [Abstract][Full Text] [Related]
2. Analytical Validation of an Automated Semiconductor-Based Next-Generation Sequencing Assay for Detection of DNA and RNA Alterations in Myeloid Neoplasms.
Zbieranski N; Insuasti-Beltran G
J Mol Diagn; 2024 Jan; 26(1):29-36. PubMed ID: 37879438
[TBL] [Abstract][Full Text] [Related]
3. Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms.
Sande CM; Wu R; Yang G; Sussman RT; Bigdeli A; Rushton C; Chitturi A; Patel J; Szankasi P; Morrissette JJD; Lim MS; Elenitoba-Johnson KSJ
J Mol Diagn; 2023 Feb; 25(2):87-93. PubMed ID: 36503148
[TBL] [Abstract][Full Text] [Related]
4. Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.
Werner R; Connolly A; Bennett M; Hand CK; Burke L
J Clin Pathol; 2024 Mar; 77(4):278-283. PubMed ID: 36522176
[TBL] [Abstract][Full Text] [Related]
5. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
[TBL] [Abstract][Full Text] [Related]
6. Ion Torrent ™ Genexus ™ Integrated Sequencer and ForeNGS Analysis Software-An automatic NGS-STR workflow from DNA to profile for forensic science.
Guo F; Lang Y; Long G; Liu Z; Jing G; Zhou Y; Zhang B; Yu S
Forensic Sci Int Genet; 2022 Nov; 61():102753. PubMed ID: 35931007
[TBL] [Abstract][Full Text] [Related]
7. Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes.
Izevbaye I; Liang LY; Mather C; El-Hallani S; Maglantay R; Saini L
J Mol Diagn; 2020 Feb; 22(2):208-219. PubMed ID: 31751678
[TBL] [Abstract][Full Text] [Related]
8. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
[TBL] [Abstract][Full Text] [Related]
9. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer.
Low SK; Ariyasu R; Uchibori K; Hayashi R; Chan HT; Chin YM; Akita T; Harutani Y; Kiritani A; Tsugitomi R; Manabe R; Ogusu S; Amino Y; Kitazono S; Yanagitani N; Nakamura Y; Nishio M
Transl Lung Cancer Res; 2022 May; 11(5):711-721. PubMed ID: 35693289
[TBL] [Abstract][Full Text] [Related]
10. Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing Assay.
Ferrone CK; Wong H; Semenuk L; Werunga B; Snetsinger B; Zhang X; Zhang G; Lui J; Richard-Carpentier G; Crocker S; Good D; Hay AE; Quest G; Carson N; Feilotter HE; Rauh MJ
J Mol Diagn; 2021 Oct; 23(10):1292-1305. PubMed ID: 34365012
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
12. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
[TBL] [Abstract][Full Text] [Related]
13. Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment Analysis.
Schejbel L; Novotny GW; Breinholt MF; El Fassi D; Schöllkopf C; Hogdall E; Nørgaard P
Mol Diagn Ther; 2021 Mar; 25(2):251-266. PubMed ID: 33687704
[TBL] [Abstract][Full Text] [Related]
14. Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms.
Park J; Kim HS; Lee JM; Jung J; Kang D; Choi H; Lee GD; Son J; Park S; Cho BS; Kim HJ; Kim S; Lee JW; Chung NG; Cho B; Zhang H; Khazanov NA; Choi J; Jung JW; Kim Y; Kim M
Mol Diagn Ther; 2020 Oct; 24(5):579-592. PubMed ID: 32676933
[TBL] [Abstract][Full Text] [Related]
15. Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.
Paasinen-Sohns A; Koelzer VH; Frank A; Schafroth J; Gisler A; Sachs M; Graber A; Rothschild SI; Wicki A; Cathomas G; Mertz KD
Neoplasia; 2017 Mar; 19(3):196-206. PubMed ID: 28161563
[TBL] [Abstract][Full Text] [Related]
16. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
17. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
Garofoli A; Paradiso V; Montazeri H; Jermann PM; Roma G; Tornillo L; Terracciano LM; Piscuoglio S; Ng CKY
J Mol Diagn; 2019 Sep; 21(5):884-894. PubMed ID: 31229654
[TBL] [Abstract][Full Text] [Related]
18. Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratory.
Werner R; Crosbie R; Dorney M; Connolly A; Collins D; Hand CK; Burke L
J Clin Pathol; 2024 Jun; ():. PubMed ID: 38914446
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
[TBL] [Abstract][Full Text] [Related]
20. Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
Park K; Tran H; Eng KW; Ramazanoglu S; Marrero Rolon RM; Scognamiglio T; Borczuk A; Mosquera JM; Pan Q; Sboner A; Rubin MA; Elemento O; Rennert H; Fernandes H; Song W
Arch Pathol Lab Med; 2020 Dec; 144(12):1535-1546. PubMed ID: 32045275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]